Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1
The occurrence of neutralizing anti-FVIII antibodies is a major complication in the treatment of patients affected by hemophilia A. The immune response to FVIII is a complex, multi-factorial process that has been extensively studied for the past two decades. The reasons why only a proportion of hemo...
Main Authors: | Davide Matino, Sajjad Afraz, George Zhao, Paul Tieu, Marco Gargaro, Francesca Fallarino, Alfonso Iorio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00620/full |
Similar Items
-
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA
by: Davide Matino, et al.
Published: (2020-01-01) -
FVIII Immunity : early events and tolerance mechanisms to FVIII
by: Qadura, Mohammad Imad
Published: (2008) -
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
by: Raimondo De Cristofaro, et al.
Published: (2019-04-01) -
Flow-Cytometry Platform for Intracellular Detection of FVIII in Blood Cells: A New Tool to Assess Gene Therapy Efficiency for Hemophilia A
by: Muhammad Elnaggar, et al.
Published: (2020-06-01) -
Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective
by: Daniela Paola Roggeri, et al.
Published: (2020-06-01)